Physician profile
Divyang R Patel
NPI 1134147796
$6,599.05
in general payments reported to CMS, 2019-2025
47 companies · $502 in 2025
The $502 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,097 · 2020: $495 · 2021: $1,083 · 2022: $857 · 2023: $1,261 · 2024: $1,303 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,066.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,065.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $977.05 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $699.62 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $528.06 | 2019-2025 | Farxiga, Lokelma |
| Abiomed | $407.33 | 2024-2025 | Impella |
| Merck Sharp & Dohme LLC | $404.43 | 2021-2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $311.54 | 2022-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $282.23 | 2019-2024 | Xarelto |
| Amgen INC. | $258.82 | 2019-2022 | |
| Pfizer INC. | $239.43 | 2019-2024 | |
| Abbott Laboratories | $205.76 | 2020-2025 | Aveir, Perclose Prostyle |
| Preventric Diagnostics, INC. | $191.87 | 2021 | |
| Inari Medical, INC. | $184.28 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $144.41 | 2021-2022 | |
| Vital Connect, INC | $144.18 | 2024 | Vitalpatch Rtm |
| Boston Scientific Corporation | $134.76 | 2020-2025 | General - Vascular Access, Watchman Flx |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Divyang Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.